Chargement en cours...
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
Rasagiline is a monoamine oxidase type-B inhibitor used as monotherapy or in addition to levodopa in the treatment of Parkinson’s disease. Once daily administration of rasagiline makes it easy to use, and allows good compliance by patients and adherence to therapy. Several multicenter studies have n...
Enregistré dans:
| Publié dans: | Neurol Ther |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Healthcare
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381918/ https://ncbi.nlm.nih.gov/pubmed/26000219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-013-0014-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|